Abstract
Type 2 myocardial infarction (MI) is defined by elevated cardiac biomarkers and evidence of ischemia due to a mismatch in myocardial oxygen supply and demand. Type 2 MI patients are usually misclassified under the diagnosis of non-ST-segment-elevation myocardial infarction (NSTEMI) despite the
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
